Biologic and Biosimilars

biosimilar is a biological product that is approved based on indicating that it is more similar to a FDA approved biologic product, known as a reference product, and has no clinical differences in terms of safety and efficacy from the reference product. Only minute differences in clinically inactive components are allowable in biosimilar products. Biologic is a substance that is made from a living organism or its products and is used in the diagnosis, treatment or prevention of cancer and other diseases. Biological drugs include vaccines, interleukins, and antibodies.

  • Biosimilars Development
  • Biosimilars in Therapeutics 
  • Clinical Trials of Biosimilars
  • Biosimilars Pipeline
  • Biosimilars in Oncology

Related Conference of Biologic and Biosimilars

Biologic and Biosimilars Conference Speakers